ArticleHealth science reports2026
Transforming Hematology Care in Africa: Strategies for Enhanced Diagnosis and Treatment.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transforming hematology care in LMICs: strategies for enhanced diagnosis and treatment.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hematologic disorders contribute significantly to morbidity and mortality across Africa. Challenges include delayed diagnosis, limited access to essential therapies, workforce shortages, and fragmented blood transfusion services. Although global advances in diagnostics and therapeutics exist, their translation into African contexts remains inconsistent. Objective: To provide a comprehensive narrative review of the current state of hematology care in Africa, highlighting diagnostic and treatment gaps, country-level experiences, and evidence-informed strategies for improving patient outcomes. Methods: A structured literature search was conducted using PubMed, Scopus, and Web of Science for publications from 2018 to 2025. Search terms included "hematology Africa," "sickle cell disease," "blood disorders," "diagnostics," "blood transfusion," and "hematologic malignancies." Studies were selected based on relevance to diagnostic strategies, treatment interventions, health system strengthening, and country-level programs. Thematic synthesis was used to identify recurrent challenges and strategic interventions. Results: Key challenges in hematology care include limited access to advanced diagnostics, insufficient laboratory and clinical workforce, inconsistent availability of essential medicines, and weak blood transfusion infrastructure. Country-level examples illustrate both successes and gaps: Rwanda has implemented neonatal sickle cell screening and drone-assisted blood delivery; Nigeria has regional sickle cell centers, but uneven coverage; Uganda and Kenya have improved diagnostic capacity through regional referral laboratories and point-of-care testing; Ghana has expanded access to targeted therapies for chronic myeloid leukemia via national health insurance programs. Strategic interventions include decentralizing diagnostics, expanding point-of-care testing, strengthening blood services, enhancing workforce training and CME, leveraging digital health and teleconsultation, and promoting regional centers of excellence. Collaborative initiatives and context-adapted policies are critical for sustainability. Conclusion: Transforming hematology care in Africa requires integrated, evidence-informed strategies combining technological innovation with health system strengthening. Country-specific experiences highlight actionable pathways, while persistent gaps underscore the need for scalable, equitable, and sustainable approaches. Coordinated efforts in diagnostics, therapeutics, workforce development, and service delivery can improve outcomes for patients with hematologic disorders across the continent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.